CVNA Carvana
NYSE · SEC CIK 1690820 · EDGAR
- Bought, last 12 months
- $1.55M 2 purchases by 1 insiders
- Sold, last 12 months
- $319.28M 83 sales by 12 insiders
- Filings on record
- 973 since 2021-07-01, latest 2026-09-16 13:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| HUSTON BENJAMIN E. | COO | — | $70.05M |
| JENKINS MARK W. | CFO | — | $54.78M |
| GILL DANIEL J. | Chief Product Off | — | $54.17M |
| Taira Thomas | Pres, Special Projects | — | $36.85M |
| GARCIA ERNEST C. III | CEO, Dir, 10% | — | $35.10M |
| KEETON RYAN S. | Chief Brand Off | — | $24.27M |
| BREAUX PAUL W. | See Remarks | — | $19.49M |
| MAROONE MICHAEL E | Dir | $1.55M | $12.38M |
| Palmer Stephen R | VP of Accounting | — | $4.29M |
| PLATT IRA J. | Dir | — | $3.24M |
Transactions 1,417
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-03 | 2025-01-01 | CVNA | Palmer Stephen R | VP of Accounting | F - Tax | $203.36 | -722 | 50.9K | -1% | -$146.8K | |
| 2025-01-03 | 2025-01-01 | CVNA | GILL DANIEL J. | Chief Product Off | F - Tax | $203.36 | -779 | 190.4K | -0.4% | -$158.4K | |
| 2025-01-03 | 2025-01-01 | CVNA | KEETON RYAN S. | Chief Brand Off | F - Tax | $203.36 | -295 | 150.7K | -0.2% | -$60.0K | |
| DM | 2025-01-03 | 2025-01-02 | CVNA | JENKINS MARK W. | CFO | S - Sale+OE | $200.75 | -10.0K | 195.5K | -5% | -$2.01M |
| D | 2025-01-03 | 2025-01-01 | CVNA | JENKINS MARK W. | CFO | F - Tax | $203.36 | -664 | 189.1K | -0.3% | -$135.0K |
| D | 2025-01-03 | 2025-01-02 | CVNA | JENKINS MARK W. | CFO | M - OptEx | $10.07 | +10.0K | 199.1K | +5% | +$100.7K |
| 2025-01-03 | 2025-01-01 | CVNA | Taira Thomas | Pres, Special Projects | F - Tax | $203.36 | -383 | 166.1K | -0.2% | -$77.9K | |
| M | 2024-12-13 | 2024-12-12 | CVNA | KEETON RYAN S. | Chief Brand Off | S - Sale | $247.90 | -24.8K | 151.0K | -14% | -$6.16M |
| MI | 2024-12-13 | 2024-12-13 | CVNA | PLATT IRA J. | Dir | G - Gift | $0.00 | 0 | 40.0K | New | $0 |
| D | 2024-12-12 | 2024-12-10 | CVNA | PLATT IRA J. | Dir | C - Cnv Deriv | $0.00 | +25.0K | 30.2K | +478% | $0 |
| DM | 2024-12-12 | 2024-12-10 | CVNA | PLATT IRA J. | Dir | S - Sale | $244.30 | -25.0K | 20.7K | -55% | -$6.11M |
| 2024-12-03 | 2024-12-01 | CVNA | KEETON RYAN S. | Chief Brand Off | F - Tax | $260.42 | -391 | 175.9K | -0.2% | -$101.8K | |
| 2024-12-03 | 2024-12-01 | CVNA | HUSTON BENJAMIN E. | COO | F - Tax | $260.42 | -971 | 216.7K | -0.4% | -$252.9K | |
| DM | 2024-12-03 | 2024-12-02 | CVNA | JENKINS MARK W. | CFO | S - Sale+OE | $255.07 | -10.0K | 190.1K | -5% | -$2.55M |
| D | 2024-12-03 | 2024-12-02 | CVNA | JENKINS MARK W. | CFO | M - OptEx | $10.07 | +10.0K | 199.8K | +5% | +$100.7K |
| D | 2024-12-03 | 2024-12-01 | CVNA | JENKINS MARK W. | CFO | F - Tax | $260.42 | -971 | 189.8K | -0.5% | -$252.9K |
| 2024-12-03 | 2024-12-01 | CVNA | GARCIA ERNEST C. III | CEO, Dir, 10% | F - Tax | $260.42 | -980 | 902.7K | -0.1% | -$255.2K | |
| M | 2024-12-03 | 2024-12-02 | CVNA | GILL DANIEL J. | Chief Product Off | S - Sale | $259.47 | -44.0K | 191.2K | -19% | -$11.42M |
| 2024-12-03 | 2024-12-01 | CVNA | GILL DANIEL J. | Chief Product Off | F - Tax | $260.42 | -1,042 | 235.2K | -0.4% | -$271.4K | |
| 2024-12-03 | 2024-12-01 | CVNA | BREAUX PAUL W. | See Remarks | F - Tax | $260.42 | -617 | 133.8K | -0.5% | -$160.7K | |
| 2024-12-03 | 2024-12-01 | CVNA | Taira Thomas | Pres, Special Projects | F - Tax | $260.42 | -529 | 166.5K | -0.3% | -$137.8K | |
| 2024-12-03 | 2024-12-01 | CVNA | Palmer Stephen R | VP of Accounting | F - Tax | $260.42 | -606 | 51.6K | -1% | -$157.8K | |
| 2024-11-12 | 2024-11-11 | CVNA | GILL DANIEL J. | Chief Product Off | S - Sale | $250.16 | -11.0K | 236.3K | -4% | -$2.75M | |
| DM | 2024-11-12 | 2024-11-08+ | CVNA | JENKINS MARK W. | CFO | S - Sale | $247.83 | -40.0K | 170.7K | -19% | -$9.91M |
| DM | 2024-11-12 | 2024-11-12 | CVNA | JENKINS MARK W. | CFO | C - Cnv Deriv | $0.00 | +40.0K | 170.7K | +31% | $0 |
| DM | 2024-11-06 | 2024-11-04+ | CVNA | JENKINS MARK W. | CFO | S - Sale+OE | $227.04 | -268.5K | 287.4K | -48% | -$60.96M |
| DM | 2024-11-06 | 2024-11-06 | CVNA | JENKINS MARK W. | CFO | C - Cnv Deriv | $0.00 | +160.0K | 190.7K | +521% | $0 |
| DM | 2024-11-06 | 2024-11-04 | CVNA | JENKINS MARK W. | CFO | M - OptEx | $28.56 | +108.5K | 299.2K | +57% | +$3.10M |
| 2024-11-06 | 2024-11-05 | CVNA | SULLIVAN GREGORY B | Dir | S - Sale | $235.00 | -5,000 | 53.4K | -9% | -$1.18M | |
| 2024-11-05 | 2024-11-01 | CVNA | Palmer Stephen R | VP of Accounting | F - Tax | $229.08 | -607 | 52.8K | -1% | -$139.1K | |
| 2024-11-05 | 2024-11-05 | CVNA | Palmer Stephen R | VP of Accounting | G - Gift | $0.00 | -500 | 52.3K | -0.9% | $0 | |
| 2024-11-01 | 2024-10-31 | CVNA | HUSTON BENJAMIN E. | COO | S - Sale | $240.00 | -3,043 | 218.7K | -1% | -$730.3K | |
| M | 2024-11-01 | 2024-10-30+ | CVNA | HUSTON BENJAMIN E. | COO | F - Tax | $209.39 | -10.2K | 217.7K | -4% | -$2.13M |
| 2024-11-01 | 2024-10-30 | CVNA | HUSTON BENJAMIN E. | COO | A - Grant | $0.00 | +22.2K | 230.9K | +11% | $0 | |
| M | 2024-11-01 | 2024-10-30+ | CVNA | Taira Thomas | Pres, Special Projects | F - Tax | $209.12 | -6,358 | 167.0K | -4% | -$1.33M |
| 2024-11-01 | 2024-10-30 | CVNA | Taira Thomas | Pres, Special Projects | A - Grant | $0.00 | +14.1K | 173.4K | +9% | $0 | |
| M | 2024-11-01 | 2024-10-31+ | CVNA | GILL DANIEL J. | Chief Product Off | S - Sale | $240.24 | -45.0K | 250.0K | -15% | -$10.81M |
| M | 2024-11-01 | 2024-10-30+ | CVNA | GILL DANIEL J. | Chief Product Off | F - Tax | $209.39 | -10.9K | 293.3K | -4% | -$2.28M |
| 2024-11-01 | 2024-10-30 | CVNA | GILL DANIEL J. | Chief Product Off | A - Grant | $0.00 | +19.9K | 303.2K | +7% | $0 | |
| M | 2024-11-01 | 2024-10-30+ | CVNA | KEETON RYAN S. | Chief Brand Off | F - Tax | $209.14 | -4,651 | 176.3K | -3% | -$972.7K |
| 2024-11-01 | 2024-10-30 | CVNA | KEETON RYAN S. | Chief Brand Off | A - Grant | $0.00 | +10.3K | 180.9K | +6% | $0 | |
| 2024-11-01 | 2024-10-30 | CVNA | JENKINS MARK W. | CFO | A - Grant | $0.00 | +22.2K | 200.9K | +12% | $0 | |
| M | 2024-11-01 | 2024-10-30+ | CVNA | JENKINS MARK W. | CFO | F - Tax | $209.39 | -10.2K | 191.7K | -5% | -$2.13M |
| M | 2024-11-01 | 2024-10-30+ | CVNA | GARCIA ERNEST C. III | CEO, Dir, 10% | F - Tax | $209.39 | -10.2K | 904.7K | -1% | -$2.15M |
| 2024-11-01 | 2024-10-30 | CVNA | GARCIA ERNEST C. III | CEO, Dir, 10% | A - Grant | $0.00 | +22.4K | 914.0K | +3% | $0 | |
| DM | 2024-11-01 | 2024-10-30+ | CVNA | BREAUX PAUL W. | See Remarks | F - Tax | $209.39 | -6,446 | 134.4K | -5% | -$1.35M |
| D | 2024-11-01 | 2024-10-31 | CVNA | BREAUX PAUL W. | See Remarks | M - OptEx | $10.07 | +30.0K | 165.0K | +22% | +$302.1K |
| DM | 2024-11-01 | 2024-10-31 | CVNA | BREAUX PAUL W. | See Remarks | S - Sale+OE | $240.22 | -30.0K | 135.0K | -18% | -$7.21M |
| D | 2024-11-01 | 2024-10-30 | CVNA | BREAUX PAUL W. | See Remarks | A - Grant | $0.00 | +14.1K | 140.9K | +11% | $0 |
| DMT | 2024-10-25 | 2024-10-23+ | CVNA | GARCIA ERNEST C. II | 10% | S - Sale | $198.24 | -200.0K | 89.5K | -69% | -$39.65M |
| DMT | 2024-10-25 | 2024-10-23+ | CVNA | GARCIA ERNEST C. II | 10% | J - Other | — | -200.0K | 37.56M | -0.5% | — |
| DMT | 2024-10-25 | 2024-10-23+ | CVNA | GARCIA ERNEST C. II | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-25 | 2024-10-25 | CVNA | ECG II SPE, LLC | 10% | S - Sale | $201.16 | -15.8K | 15.1K | -51% | -$3.18M |
| DT | 2024-10-25 | 2024-10-25 | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -15.8K | 37.44M | -0.0% | — |
| DT | 2024-10-25 | 2024-10-25 | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +15.8K | 15.8K | New | — |
| M | 2024-10-24 | 2024-10-23+ | CVNA | GILL DANIEL J. | Chief Product Off | S - Sale | $200.11 | -44.0K | 324.4K | -12% | -$8.81M |
| DM | 2024-10-24 | 2024-10-23 | CVNA | BREAUX PAUL W. | See Remarks | C - Cnv Deriv | $0.00 | +32.7K | 127.3K | +35% | $0 |
| DM | 2024-10-24 | 2024-10-22+ | CVNA | BREAUX PAUL W. | See Remarks | S - Sale+OE | $198.00 | -40.0K | 119.5K | -25% | -$7.92M |
| D | 2024-10-24 | 2024-10-22 | CVNA | BREAUX PAUL W. | See Remarks | M - OptEx | $10.07 | +6,769 | 134.0K | +5% | +$68.2K |
| DMT | 2024-10-23 | 2024-10-21+ | CVNA | ECG II SPE, LLC | 10% | S - Sale | $192.94 | -200.0K | 84.5K | -70% | -$38.59M |
| DMT | 2024-10-23 | 2024-10-21+ | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-23 | 2024-10-21+ | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -200.0K | 37.66M | -0.5% | — |
| DMT | 2024-10-21 | 2024-10-17+ | CVNA | ECG II SPE, LLC | 10% | S - Sale | $191.89 | -200.0K | 2,778 | -99% | -$38.38M |
| DMT | 2024-10-21 | 2024-10-17+ | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -200.0K | 37.86M | -0.5% | — |
| DMT | 2024-10-21 | 2024-10-17+ | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-17 | 2024-10-15+ | CVNA | GARCIA ERNEST C. II | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-17 | 2024-10-15+ | CVNA | GARCIA ERNEST C. II | 10% | S - Sale | $192.38 | -200.0K | 77.2K | -72% | -$38.48M |
| DMT | 2024-10-17 | 2024-10-15+ | CVNA | GARCIA ERNEST C. II | 10% | J - Other | — | -200.0K | 38.16M | -0.5% | — |
| DMT | 2024-10-15 | 2024-10-11+ | CVNA | ECG II SPE, LLC | 10% | S - Sale | $191.51 | -200.0K | 69.0K | -74% | -$38.30M |
| DMT | 2024-10-15 | 2024-10-11+ | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -200.0K | 38.26M | -0.5% | — |
| DMT | 2024-10-15 | 2024-10-11+ | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-11 | 2024-10-09+ | CVNA | ECG II SPE, LLC | 10% | S - Sale | $190.47 | -200.0K | 0 | -100% | -$38.09M |
| DMT | 2024-10-11 | 2024-10-09+ | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -200.0K | 38.46M | -0.5% | — |
| DMT | 2024-10-11 | 2024-10-09+ | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-09 | 2024-10-07+ | CVNA | ECG II SPE, LLC | 10% | S - Sale | $183.72 | -200.0K | 93.6K | -68% | -$36.74M |
| DMT | 2024-10-09 | 2024-10-07+ | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -200.0K | 38.66M | -0.5% | — |
| DMT | 2024-10-09 | 2024-10-07+ | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-07 | 2024-10-03+ | CVNA | GARCIA ERNEST C. II | 10% | S - Sale | $177.75 | -200.0K | 95.7K | -68% | -$35.55M |
| DMT | 2024-10-07 | 2024-10-03+ | CVNA | GARCIA ERNEST C. II | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-07 | 2024-10-03+ | CVNA | GARCIA ERNEST C. II | 10% | J - Other | — | -200.0K | 38.86M | -0.5% | — |
| DMT | 2024-10-03 | 2024-10-01+ | CVNA | ECG II SPE, LLC | 10% | S - Sale | $174.91 | -200.0K | 33.9K | -85% | -$34.98M |
| DMT | 2024-10-03 | 2024-10-01+ | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-03 | 2024-10-01+ | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -200.0K | 39.06M | -0.5% | — |
| 2024-10-03 | 2024-10-01 | CVNA | GILL DANIEL J. | Chief Product Off | F - Tax | $175.80 | -1,042 | 327.3K | -0.3% | -$183.2K | |
| 2024-10-03 | 2024-10-01 | CVNA | Taira Thomas | Pres, Special Projects | F - Tax | $175.80 | -529 | 159.3K | -0.3% | -$93.0K | |
| 2024-10-03 | 2024-10-01 | CVNA | Palmer Stephen R | VP of Accounting | F - Tax | $175.80 | -607 | 53.4K | -1% | -$106.7K | |
| 2024-10-03 | 2024-10-01 | CVNA | HUSTON BENJAMIN E. | COO | F - Tax | $175.80 | -971 | 208.7K | -0.5% | -$170.7K | |
| 2024-10-03 | 2024-10-01 | CVNA | GARCIA ERNEST C. III | CEO, Dir, 10% | F - Tax | $175.80 | -981 | 891.5K | -0.1% | -$172.5K | |
| 2024-10-03 | 2024-10-01 | CVNA | BREAUX PAUL W. | See Remarks | F - Tax | $175.80 | -617 | 127.3K | -0.5% | -$108.5K | |
| 2024-10-03 | 2024-10-01 | CVNA | JENKINS MARK W. | CFO | F - Tax | $175.80 | -971 | 178.7K | -0.5% | -$170.7K | |
| 2024-10-03 | 2024-10-01 | CVNA | KEETON RYAN S. | Chief Brand Off | F - Tax | $175.80 | -391 | 170.6K | -0.2% | -$68.7K | |
| DMT | 2024-10-01 | 2024-09-27+ | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-10-01 | 2024-09-27+ | CVNA | ECG II SPE, LLC | 10% | S - Sale | $170.78 | -200.0K | 0 | -100% | -$34.16M |
| DMT | 2024-10-01 | 2024-09-27+ | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -200.0K | 39.26M | -0.5% | — |
| DMT | 2024-09-27 | 2024-09-25+ | CVNA | ECG II SPE, LLC | 10% | S - Sale | $169.41 | -200.0K | 32.6K | -86% | -$33.88M |
| DMT | 2024-09-27 | 2024-09-25+ | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -200.0K | 39.46M | -0.5% | — |
| DMT | 2024-09-27 | 2024-09-25+ | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
| DMT | 2024-09-25 | 2024-09-23+ | CVNA | ECG II SPE, LLC | 10% | S - Sale | $171.97 | -200.0K | 300 | -100% | -$34.39M |
| DMT | 2024-09-25 | 2024-09-23+ | CVNA | ECG II SPE, LLC | 10% | J - Other | — | -200.0K | 39.66M | -0.5% | — |
| DMT | 2024-09-25 | 2024-09-23+ | CVNA | ECG II SPE, LLC | 10% | C - Cnv Deriv | — | +200.0K | 100.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations